Shenzhou Cell voluntarily disclosed an announcement that its holding subsidiary product SCTB14 obtained a notice of approval for drug clinical trials

SZSI · Apr 11

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.